EUCTR2010-019438-28-SE进行中（未招募）不适用
Vaccination against TBE in patients who use immunosuppressive drugs
Mälarsjukhuset Eskilstuna0 个研究点开始时间: 2010年3月18日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients treated with immunosuppressive medication for treatment of rheumatoid arthritis (RA) or Psoriasis and desiring protection against TBE
- •Men and women 18 years or older.
- •Signed informed consent
- •Women of childbearing age must use a safe method of contraception such as oral contraceptives or abstinence during the study period.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Previous TBE infection
- •Previous vaccination with TBE vaccine
- •Hypersensitivity or allergy to eggs.
- •Treatment with rituximab within the last 9 months before inclusion
- •Pregnant or lactating
- •If the investigator for any other reason considers the patient unsuitable for inclusion. For example, in the presence of some other serious disease (eg AIDS / HIV positive, ongoing cancer chemotherapy).
- •Hypersensitivity to the active substance or any of the excipients.
研究者
相似试验
已完成
4 期
TBE (Tick-borne Encephalitis) Vaccination in Allergic PatientsVaccine Responsiveness in AllergyVaccine Responsiveness During Allergy De-sensitization TreatmentNCT02511535Medical University of Vienna119
已完成
不适用
Basic immunization against TBE in persons over fifty years with FSME-IMMUN AdultsProphylaxis of TBE in adult persons over fifty years A84.1A84.1Central European tick-borne encephalitisDRKS00003496Baxter Deutschland GmbH411
尚未招募
3 期
Immunogenicity and safety after vaccinated with BBIBP-CorV (COVID-19 vaccine) in Thai pregnant womePregnant womenCOVID-19SARS-CoV-2 vaccineVaccinePregnantBBIBP-CorVSinopharmTCTR20210923013Chulabhorn Hospital400
招募中
不适用
Intradermal Hepatitis-B-vaccination in non-responders after application of imiquimod 5% at the site of vaccination.non-responsiveness to hepatitis B vaccination (with recombinant vaccine).NL-OMON24074A.H.E. Roukens, MDL.G. Visser, MD, PhD26
进行中（未招募）
1 期
Vaccination of antibody deficient patients with Prevenar13 - a comparative study between antibody response and cellular immunity.Patients with IgG-deficiencyEUCTR2012-004486-41-SEKarolinska University Hospital, Huddinge, Sweden20